Results of a phase I dose escalation study of eltrombopag in patients with advanced soft tissue sarcoma receiving doxorubicin and ifosfamide

BACKGROUND: The objective of this Phase I dose escalation study was to explore the safety and tolerability of eltrombopag, an oral, nonpeptide, thrombopoietin receptor agonist, in patients with advanced soft tissue sarcoma (STS) and thrombocytopenia due to treatment with doxorubicin and ifosfamide (...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Chawla, Sant P, Staddon, Arthur, Hendifar, Andrew, Messam, Conrad A, Patwardhan, Rita, Kamel, Yasser Mostafa
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2013
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3605142/
https://ncbi.nlm.nih.gov/pubmed/23497336
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-13-121
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares